J9165 – Injection, diethylstilbestrol diphosphate, 250 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9165
- Long description
- Injection, diethylstilbestrol diphosphate, 250 mg
- Short description
- Diethylstilbestrol injection
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1DChemotherapy- Added
- January 1, 1988
- Last change
- January 1, 2026 – No change
- Termination date
- December 31, 2025
Frequently asked questions
What is HCPCS code J9165?
J9165 is a HCPCS Level II code for injection, diethylstilbestrol diphosphate, 250 mg. It was discontinued on December 31, 2025.
Does Medicare cover J9165?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9144 – Injection, daratumumab, 10 mg and hyaluronidase-fihj
- J9145 – Injection, daratumumab, 10 mg
- J9150 – Injection, daunorubicin, 10 mg
- J9151 – Injection, daunorubicin citrate, liposomal formulation, 10 mg
- J9153 – Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- J9155 – Injection, degarelix, 1 mg
- J9160 – Injection, denileukin diftitox, 300 micrograms
- J9161 – Injection, denileukin diftitox-cxdl, 1 mcg
- J9171 – Injection, docetaxel, 1 mg
- J9172 – Injection, docetaxel (docivyx), 1 mg
- J9173 – Injection, durvalumab, 10 mg
- J9174 – Injection, docetaxel (beizray), 1 mg
- J9175 – Injection, elliotts' b solution, 1 ml
- J9176 – Injection, elotuzumab, 1 mg
- J9177 – Injection, enfortumab vedotin-ejfv, 0.25 mg
- J9178 – Injection, epirubicin hcl, 2 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.